Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease

Abstract Background Chronic obstructive pulmonary disease (COPD) exacerbations are heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic acid (LPA) has been implicated in airway inflammation but the significance of LPA in COPD exacerbation is not known. The aim...

Full description

Bibliographic Details
Main Authors: Qingling Li, Weng Wong, Andrew Birnberg, Arindam Chakrabarti, Xiaoying Yang, David F. Choy, Julie Olsson, Erik Verschueren, Margaret Neighbors, Wendy Sandoval, Carrie M. Rosenberger, Michele A. Grimbaldeston, Gaik W. Tew
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Pulmonary Medicine
Subjects:
Serum lysophosphatidic acid species
Lipidomic
Exacerbation
Chronic obstructive pulmonary disease
Online Access:https://doi.org/10.1186/s12890-021-01670-9

Internet

https://doi.org/10.1186/s12890-021-01670-9

Similar Items